Li T, Goldstein D, Park SB. What you measure matters: the importance of outcome measures in evaluating the prevalence of painful chemotherapy-induced peripheral neuropathy. Reg Anesth Pain Med 2025 Mar 22:rapm-2025-106586. doi: 10.1136/rapm-2025-106586.
PMID: 40121025